> Using a large database of (deidentified) medical records, the researchers compared the outcomes of people taking a GLP-1 for their type 2 diabetes to people taking other common diabetes drugs between 2017 and 2025. GLP-1 users were significantly less likely to be diagnosed with TB for up to a five-year span, they found.

This is incredibly manipulative. So, we're going to ignore all other factors that may have played into this and just assume it was due directly to GLP-1 use?